Cytokinetics Inc (CYTK) - Financial and Strategic SWOT Analysis Review

May 2021 | 54 pages | ID: C67E8AA2682EN
GlobalData

Abstracts

Cytokinetics Inc (CYTK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Cytokinetics Inc (Cytokinetics) discovers, develops, and commercializes muscle activators and inhibitors for the treatment of cardiovascular and neuromuscular diseases associated with reduced muscle performance. The company’s pipeline encompasses omecamtiv mecarbil, a novel cardiac myosin activator in Phase III for heart failure; reldesemtiv, a next-generation fast skeletal muscle troponin activator in Phase II for the treatment of spinal muscular atrophy, amyotrophic lateral sclerosis; CK-271, an oral, small molecule cardiac myosin inhibitor in Phase I trials for cardiac hypertrophy, cardiac fibrosis and heart failure; CK-274, to reduce the hypertrophic cardiomyopathies and CK-136, for people with heart failure and other diseases. It is also investigating reldesemtiv for chronic obstructive pulmonary. It has licensing and collaboration agreements with Amgen, Ji Xing and Astellas for advancing its drug candidates. Cytokinetics is headquartered in South San Francisco, California, the US.

Cytokinetics Inc Key Recent Developments

May 06,2021: Cytokinetics Reports First Quarter 2021 Financial Results
May 05,2021: Cytokinetics to Hold Annual Meeting of Stockholders
Apr 05,2021: Cytokinetics to Participate in the 20th Annual Needham Virtual Healthcare Conference
Feb 26,2021: Cytokinetics : Joins European Organisation for Rare Diseases and the National Organization for Rare Disorders
Feb 25,2021: Cytokinetics reports fourth quarter 2020 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Cytokinetics Inc - Key Facts
Cytokinetics Inc - Key Employees
Cytokinetics Inc - Key Employee Biographies
Cytokinetics Inc - Major Products and Services
Cytokinetics Inc - History
Cytokinetics Inc - Company Statement
Cytokinetics Inc - Locations And Subsidiaries
Head Office

SECTION 2 – COMPANY ANALYSIS

Company Overview
Cytokinetics Inc - Business Description
Other Break-up: License revenues
Performance
Other Break-up: Milestone Revenue
Performance
Other Break-up: Research and development
Performance
R&D Overview
Cytokinetics Inc - Corporate Strategy
Cytokinetics Inc - SWOT Analysis
SWOT Analysis - Overview
Cytokinetics Inc - Strengths
Cytokinetics Inc - Weaknesses
Cytokinetics Inc - Opportunities
Cytokinetics Inc - Threats
Cytokinetics Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Cytokinetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Cytokinetics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Cytokinetics Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

May 06, 2021: Cytokinetics Reports First Quarter 2021 Financial Results
May 05, 2021: Cytokinetics to Hold Annual Meeting of Stockholders
Apr 05, 2021: Cytokinetics to Participate in the 20th Annual Needham Virtual Healthcare Conference
Feb 26, 2021: Cytokinetics : Joins European Organisation for Rare Diseases and the National Organization for Rare Disorders
Feb 25, 2021: Cytokinetics reports fourth quarter 2020 financial results
Feb 19, 2021: Cytokinetics announces resignation of L. Patrick Gage from Board of Directors
Feb 18, 2021: Cytokinetics Names Muna Bhanji to Board of Directors
Feb 11, 2021: Cytokinetics to Announce Fourth Quarter Results on February 25, 2021
Feb 02, 2021: Cytokinetics announces recipients of third annual communications fellowship grants
Dec 03, 2020: Cytokinetics announces three presentations at the International Symposium on ALS/MND

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Cytokinetics Inc, Key Facts
Cytokinetics Inc, Key Employees
Cytokinetics Inc, Key Employee Biographies
Cytokinetics Inc, Major Products and Services
Cytokinetics Inc, History
Cytokinetics Inc, Key Competitors
Cytokinetics Inc, Ratios based on current share price
Cytokinetics Inc, Annual Ratios
Cytokinetics Inc, Annual Ratios (Cont...1)
Cytokinetics Inc, Interim Ratios
Cytokinetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Cytokinetics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Cytokinetics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Cytokinetics Inc, Performance Chart (2016 - 2020)
Cytokinetics Inc, Ratio Charts
Cytokinetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Cytokinetics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021